Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Efficacy of Ritalin in Adhd Children Under Neurofeedback Training Publisher Pubmed



Pakdaman F1 ; Irani F2 ; Tajikzadeh F3 ; Jabalkandi SA4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Mehr Brain Clinic, Tehran, Iran
  2. 2. Psychology and Center for Interdisciplinary Brain Research, Jyvaskyla University, Jyvaskyla, Finland
  3. 3. Clinical Psychology, Shiraz University, Shiraz, Iran
  4. 4. Department of Clinical Psychology, Tehran University of Medical Sciences, Tehran, Iran

Source: Neurological Sciences Published:2018


Abstract

Current research has shown that neurofeedback (NF) is a viable treatment for attention deficit hyperactivity disorder (ADHD), however having pharmacological approach alongside such stimulants is still inevitable. Therefore, the purpose of this study is the comparison of neurofeedback with Ritalin and without Ritalin in treating children with ADHD. This study was causal-comparative in design. Participants were children aged 5–10 years with ADHD; seven participants were in neurofeedback group with Ritalin and seven in neurofeedback without Ritalin group according to random split and parent’s conformation. Clinical Q, Conner’s continuous performance test (CPT), and WISC-R were used before and after treatment. For analyzing data, we used descriptive statistical and Mann Whitney U tests. Results showed that even if the two groups were modified in all components, modifications of commission and reaction time of the CPT and F4 theta/alpha of the clinical Q were more accurate in NF with Ritalin treatment rather than the other group. These findings suggest that neurofeedback is efficient in improving some of the behavioral concomitants of ADHD in children whose parents favored non-pharmacological treatment, but Ritalin and neurofeedback combination is more efficient. So, multimodal approach is strongly recommended for ADHD treatment. © 2018, Springer-Verlag Italia S.r.l., part of Springer Nature.